$NEXI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NexImmune, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NexImmune, Inc.. Get notifications about new insider transactions in NexImmune, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2021 | NEXI | NexImmune, Inc. | Trainer John | Chief Financial Off ... | Option Exercise | M | 5.17 | 3,432 | 17,743 | 116,677 | |
| Mar 12 2021 | NEXI | NexImmune, Inc. | Trainer John | Chief Financial Off ... | Buy | M | 5.17 | 3,432 | 17,743 | 48,042 | 44.6 K to 48 K (+7.69 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Jones Kristi | Chief Operating Off ... | Option Exercise | C | 0.00 | 14,738 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Jones Kristi | Chief Operating Off ... | Buy | P | 17.00 | 911 | 15,487 | 63,078 | 62.2 K to 63.1 K (+1.47 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Jones Kristi | Chief Operating Off ... | Buy | C | 0.00 | 14,738 | 0 | 62,167 | 47.4 K to 62.2 K (+31.07 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Roemer Alan S. | Director | Option Exercise | C | 0.00 | 26,590 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Roemer Alan S. | Director | Option Exercise | C | 0.00 | 4,110 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Roemer Alan S. | Director | Option Exercise | C | 0.00 | 85,016 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Roemer Alan S. | Director | Buy | C | 0.00 | 12,268 | 0 | 127,984 | 115.7 K to 128 K (+10.60 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Roemer Alan S. | Director | Buy | C | 0.00 | 26,590 | 0 | 115,716 | 89.1 K to 115.7 K (+29.83 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Roemer Alan S. | Director | Buy | C | 0.00 | 4,110 | 0 | 89,126 | 85 K to 89.1 K (+4.83 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Roemer Alan S. | Director | Buy | C | 0.00 | 85,016 | 0 | 85,016 | 0 to 85 K |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Verstandig Grant | Director | Buy | P | 17.00 | 175,000 | 2,975,000 | 714,895 | 539.9 K to 714.9 K (+32.41 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Verstandig Grant | Director | Buy | C | 0.00 | 539,895 | 0 | 539,895 | 0 to 539.9 K |
| Feb 19 2021 | NEXI | NexImmune, Inc. | D'Angio Paul | Director | Option Exercise | C | 0.00 | 4,110 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | D'Angio Paul | Director | Option Exercise | C | 0.00 | 4,110 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | D'Angio Paul | Director | Option Exercise | C | 0.00 | 19,627 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | D'Angio Paul | Director | Buy | C | 0.00 | 4,110 | 0 | 27,847 | 23.7 K to 27.8 K (+17.31 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | D'Angio Paul | Director | Buy | C | 0.00 | 4,110 | 0 | 23,737 | 19.6 K to 23.7 K (+20.94 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | D'Angio Paul | Director | Buy | C | 0.00 | 19,627 | 0 | 19,627 | 0 to 19.6 K |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Carmer Scott | President and CEO | Option Exercise | C | 0.00 | 7,058 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Carmer Scott | President and CEO | Buy | C | 0.00 | 7,058 | 0 | 7,058 | 0 to 7.1 K |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Bertram Timothy | Director | Option Exercise | C | 0.00 | 16,440 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Bertram Timothy | Director | Option Exercise | C | 0.00 | 10,344 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Bertram Timothy | Director | Option Exercise | C | 0.00 | 44,965 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Bertram Timothy | Director | Buy | C | 0.00 | 16,440 | 0 | 78,199 | 61.8 K to 78.2 K (+26.62 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Bertram Timothy | Director | Buy | C | 0.00 | 10,344 | 0 | 61,759 | 51.4 K to 61.8 K (+20.12 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | Bertram Timothy | Director | Buy | C | 0.00 | 44,965 | 0 | 51,415 | 6.5 K to 51.4 K (+697.13 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | C | 0.00 | 217,570 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | C | 0.00 | 82,204 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | C | 0.00 | 164,408 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | C | 0.00 | 894,036 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | C | 0.00 | 800,182 | 0 | 0 | |
| Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 217,570 | 0 | 346,577 | 129 K to 346.6 K (+168.65 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | P | 17.00 | 60,000 | 1,020,000 | 1,538,013 | 1.5 M to 1.5 M (+4.06 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 337,365 | 0 | 1,478,013 | 1.1 M to 1.5 M (+29.58 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 82,204 | 0 | 1,140,648 | 1.1 M to 1.1 M (+7.77 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 164,408 | 0 | 1,058,444 | 894 K to 1.1 M (+18.39 %) |
| Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 894,036 | 0 | 894,036 | 0 to 894 K |
| Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 800,182 | 0 | 1,367,814 | 567.6 K to 1.4 M (+140.97 %) |
| Feb 16 2021 | NEXI | NexImmune, Inc. | ZELDIS JEROME B | Executive VP of Res ... | Option Exercise | A | 17.00 | 351,016 | 5,967,272 | 351,016 | |
| Feb 16 2021 | NEXI | NexImmune, Inc. | Yao Zhengbin | Director | Option Exercise | A | 17.00 | 9,556 | 162,452 | 32,678 | |
| Feb 16 2021 | NEXI | NexImmune, Inc. | Verstandig Grant | Director | Option Exercise | A | 17.00 | 39,096 | 664,632 | 39,096 | |
| Feb 16 2021 | NEXI | NexImmune, Inc. | Trainer John | Chief Financial Off ... | Option Exercise | A | 17.00 | 28,987 | 492,779 | 149,096 | |
| Feb 16 2021 | NEXI | NexImmune, Inc. | Roemer Alan S. | Director | Option Exercise | A | 17.00 | 9,556 | 162,452 | 104,191 | |
| Feb 16 2021 | NEXI | NexImmune, Inc. | Knight Robert Douglas | Chief Medical Offic ... | Option Exercise | A | 17.00 | 210,609 | 3,580,353 | 210,609 | |
| Feb 16 2021 | NEXI | NexImmune, Inc. | Jones Kristi | Chief Operating Off ... | Option Exercise | A | 17.00 | 84,207 | 1,431,519 | 235,144 | |
| Feb 16 2021 | NEXI | NexImmune, Inc. | D'Angio Paul | Director | Option Exercise | A | 17.00 | 9,556 | 162,452 | 45,312 | |
| Feb 16 2021 | NEXI | NexImmune, Inc. | Roemer Alan S. | Director | Option Exercise | A | 17.00 | 9,556 | 162,452 | 104,191 | |
| Feb 16 2021 | NEXI | NexImmune, Inc. | Knight Robert Douglas | Chief Medical Offic ... | Option Exercise | A | 17.00 | 210,609 | 3,580,353 | 210,609 | |
| Feb 16 2021 | NEXI | NexImmune, Inc. | Jones Kristi | Chief Operating Off ... | Option Exercise | A | 17.00 | 84,207 | 1,431,519 | 235,144 | |
| Feb 16 2021 | NEXI | NexImmune, Inc. | D'Angio Paul | Director | Option Exercise | A | 17.00 | 9,556 | 162,452 | 45,312 | |
| Feb 16 2021 | NEXI | NexImmune, Inc. | Carmer Scott | President and CEO | Option Exercise | A | 17.00 | 306,842 | 5,216,314 | 770,923 | |
| Feb 16 2021 | NEXI | NexImmune, Inc. | Carmer Scott | President and CEO | Option Exercise | A | 17.00 | 306,842 | 5,216,314 | 770,923 | |
| Feb 16 2021 | NEXI | NexImmune, Inc. | Bertram Timothy | Director | Option Exercise | A | 17.00 | 9,556 | 162,452 | 45,312 | |
| Feb 16 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | A | 17.00 | 19,113 | 324,921 | 225,013 |
Page: 1